- Adults
- General population
- Elderly
- Hospital wide
- SARS-CoV-2
- Post-COVID-19
Population: Adults
Individuals aged 18-64 years
- Adults
- General population
- Elderly
- Hospital wide
- Intensive care unit
- SARS-CoV-2
- Post-COVID-19
- Blood sample
- Adults
- Elderly
- Paediatric
- Community
- SARS-CoV-2
- Post-COVID-19
- Adults
- Paediatric
- Community
- SARS-CoV-2
- Acute SARS-CoV-2
- Nasopharyngeal swab
- Non pharmacological intervention
- Adults
- Elderly
- Fragile population
- Infectious diseases unit
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Monoclonal antibodies
- Tixagevimab/Cilgavimab
- Adults
- Elderly
- Fragile population
- Hospital wide
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Remdesivir
- Monoclonal antibodies
- Sotrovimab
- Molnupiravir
- Tixagevimab/Cilgavimab
- Casirivimab/Imdevimab
- Adults
- Elderly
- Fragile population
- Hospital wide
- Outpatient clinic
- Community
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Remdesivir
- Adults
- Elderly
- Fragile population
- Immunocompromised host
- Hospital wide
- Infectious diseases unit
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Remdesivir
- Monoclonal antibodies
- Sotrovimab
- Adults
- Elderly
- Fragile population
- Hospital wide
- Intensive care unit
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Remdesivir
- Immnunomodulator
- Steroids
- Baricitinib
- Dexamethasone
- Methylprednisolone
- Adults
- General population
- Elderly
- Hospital wide
- Emergency department
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Adults
- General population
- Elderly
- Hospital wide
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antibiotics
- Adults
- Elderly
- Fragile population
- Hospital wide
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antibiotic
- Azithromycin